Articles

Quality first: advanced manufacturing process for EZ-fill® cartridges The development of GLP-1 drugs has revolutionized the treatment of diabetes and obesity – and is a catalyst for breaking new grounds in ready-to-use cartridge manufacturing. Primary packaging provider Stevanato Group has...

As life sciences supply chains become more volatile, real-time visibility is increasingly the baseline for operational excellence. The next frontier is orchestration: turning fragmented signals into decisions that prevent excursions, reduce waste, and protect patients.  Sam Durham, Product Manager...

Late-stage development is where timelines tighten, complexity increases, and the demand for speed becomes most visible. Execution is often treated as the lever—compressed timelines, parallel workstreams, faster decision-making. But speed is rarely created at that stage. It is shaped earlier,...

Why Field Execution Must Evolve Field execution — how pharma companies organize, direct, and deliver commercial and medical interactions with healthcare professionals (HCPs), prescribers, and institutional decision-makers (collectively, "customers") — is a major contributor to commercial success. Accordingly, over the...

A blister pack may seem like a simple enough concept until you’re trying to prove that it will open cleanly every time. Peel testing turns each peel into data so you can protect dose integrity, support and child resistance...

The protection of patient health starts with ensuring the safety of pharmaceutical products even before they reach healthcare providers. Every recall caused by defective or leaking containers is one too many. As the pharmaceutical industry continues to evolve towards...

Modern drug development necessitates a shift from fragmented data silos to a unified, intelligence-driven framework. Achieving global regulatory alignment requires a sophisticated approach to trial documentation standards and pharmaceutical regulatory governance, ensuring that clinical trial design remains robust across multiple jurisdictions. By leveraging standardized drug intelligence, sponsors can enhance submission readiness and maintain cross-border compliance, ultimately accelerating the delivery of life-saving therapies to patients worldwide.